This report was first published by Endpoints News. To see the original version, click here
The White House on Friday announced new deals with nine major drugmakers, finalizing an end-of-year push by President Donald Trump to make good on his “most favored nation” pledge for lower medicine prices.
Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Genentech, GSK, Gilead, Merck, Novartis and Sanofi agreed to sell select medicines at lowered prices along the lines of some European and other comparable countries.
您已阅读13%（512字），剩余87%（3451字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。